Melissa officinalis Protects against Doxorubicin-Induced Cardiotoxicity in Rats and Potentiates Its Anticancer Activity on MCF-7 Cells.
Cardiotoxicity is a limiting factor of doxorubicin (DOX)-based anticancer therapy. Due to its beneficial effects, we investigated whether standardized extract of Melissa officinalis (MO) can attenuate doxorubicin-induced cardiotoxicity and can potentiate the efficacy of DOX against human breast canc...
Main Authors: | Alaaeldin Ahmed Hamza, Mahguob Mohamed Ahmed, Hanan Mohamed Elwey, Amr Amin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5120835?pdf=render |
Similar Items
-
Evaluation of antioxidant and anticancer effects of Lavandula angustifolia and Melissa officinalis on HeLa, OVCAR-3 and MCF-7 cancer cell lines
by: Parichehr Hanachi, et al.
Published: (2021-06-01) -
Polyphenolic-enriched olive leaf extract attenuated doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress and inflammation
by: Alaaeldin Ahmed Hamza, et al.
Published: (2021-10-01) -
Anticancer Effects of Melissa officinalis: A Traditional Medicine
by: Parviz Faraji, et al.
Published: (2022-07-01) -
Green synthesis of silver nanoparticles, graphene, and silver-graphene nanocomposite using Melissa officinalis ethanolic extract: Anticancer effect on MCF-7 cell line
by: Farzaneh Motafeghi, et al.
Published: (2023-01-01) -
Protective effect of nebivolol on doxorubicin-induced cardiotoxicity in rats
by: Enas Ahmed Mohamed, et al.
Published: (2018-10-01)